Boston, Feb. 05, 2016 -- Informa’s Pharma Intelligence– the world’s leading provider of clinical and research intelligence and analysis, and home of leading brands such as Sitetrove, In Vivo, Pink Sheet, Scrip and Biomedtracker – is announcing the launch of the first annual Clinical and Research Excellence Awards. The CARE Awards, as they will be known throughout the pharma and healthcare industry, will be held in Boston’s State Room on 27th April, 2016, and will recognize the outstanding achievements of the global clinical research enterprise.
“The CARE Awards will gather together distinguished leaders in the biopharmaceutical, CRO and diagnostic industries from all corners of the globe,” says Alex Shimmings, Editor of Scrip.
“These awards are designed to be the pre-eminent awards for clinical and research excellence and will celebrate the brilliant minds, strategic thinkers and risk takers who bring the hope and promise of good health to humankind across the globe,” adds Shimmings. “We are celebrating those individuals and companies who have dedicated themselves to improving the health and well-being of others.”
The CARE Awards features 12 categories that reward innovation, technological development, collaboration and excellence in areas such as successful trials, clinical trial design, R&D excellence, partnerships and lifetime achievement.
“The CARE Awards provides our industry with the opportunity to showcase those who work in clinical research and development and to honor both individuals and companies that shine through innovation, excellence and leadership,” explains Doro Shin, Principal Analyst at Citeline, the world’s leading authority on pharmaceutical clinical trials.
Nominations for the CARE Awards is free and all submissions should be made via the online entry form available here www.clinicalresearchexcellence.com. A panel of distinguished industry experts will rigorously assess entries and decide upon winners in each of the categories for the 2016 CARE Awards.
The first annual CARE Awards categories include:
- Most Successful Early Phase Trial (Preclinical & Phase I)
- Most Innovative Clinical Trial Design
- Clinical Trial Result of the Year
- Best Advance in Biomarkers
- Best Technological Development in Clinical Trials
- R&D Team of the Year
- Clinical Research Team of the Year
- Clinical Partnership of the Year
- Best Use of Companion Diagnostic
- Best Newcomer (Company)
- Marquee Award ‘R&D Excellence’
- Lifetime Achievement
“Innovative thinking, determination to succeed and dedication to improving healthcare are hallmarks of our great industry,” continues Shin. “The 2016 shortlisted candidates will all share the attributes that make clinical R&D both a global economic force and a force for the good of humankind. Together with our esteemed panel of judges, we look forward to a strong ‘class of 2016’ and we welcome entries from around the world.”
-ENDS-
For press enquiries contact:
Kirstin Stocker
Tel: +44 (0)207 017 7290
Mobile: +44 (0)79 205 00400
Email: [email protected]
For Sponsorship enquiries contact:
Matt Dias Tel: +44 (0)207 017 4188
Mobile: +44 (0)770 235 3220
Email: [email protected]
For all other enquiries contact:
Jo Kirkpatrick (UK)
Tel: +44 (0) 207 017 7180
Email: [email protected]
About Pharma intelligence
Pharma intelligence is home of the world’s leading pharma and healthcare R&D and business intelligence brands – Datamonitor Healthcare, Sitetrove, Trialtrove, Pharmaprojects, Medtrack, Biomedtracker, Scrip, Pink Sheet, In Vivo. Pharma intelligence’s brands are trusted to provide over 3000 of the world’s leading pharmaceutical, contract research organisations (CRO’s), medical technology, biotechnology and healthcare service providers, including the top 10 global pharma and top 10 CRO’s, with an advantage when making critical R&D and commercial decisions.


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 



